Kristensen A T, Feldman B F
Health Care Discovery, Novo Nordisk A/S, Gentofte, Denmark.
Vet Clin North Am Small Anim Pract. 1995 Nov;25(6):1277-90. doi: 10.1016/s0195-5616(95)50154-8.
Administration of blood components instead of whole blood has become the most important means of transfusion support in dogs and in some settings in cats as well. Component administration entails the transfer of biological material and carries an inherent risk of disease transmission and adverse reactions. This article reviews the indications, pretransfusion considerations, and follow up in small animal patients receiving blood component therapy.
输注血液成分而非全血，已成为犬类以及某些情况下猫科动物输血支持的最重要手段。成分输血涉及生物材料的转移，存在疾病传播和不良反应的固有风险。本文综述了接受血液成分治疗的小动物患者的适应证、输血前注意事项及后续处理。
